Sphinganine

From NuGOwiki

(Redirected from HMDB00269)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Sphinganine
2D structure for Sphinganine
Chemical Name (2S,3R)-2-amino-1,3-Octadecanediol
Chemical Formula C18H39NO2
CAS Number 764-22-7
Chemical Information HMDB00269
Biochemical Taxonomy

  • Amino Alcohols

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Glycerolipid Metabolism
  • Glycerophospholipid Metabolism
  • Glycosphingolipid Metabolism

Biofluid Location

  • Blood

Tissue Location

  • Intestine
  • Kidney
  • Liver
  • Platelet
  • Spleen
  • Stratum Corneum
  • Thyroid Gland
  • Fibroblasts

Normal Biofluid Concentrations

  • Blood: 0.011 +/- 0.00033 umol/L

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition Not Available
Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations Not Available
Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
Sphinganine is a blocker postlysosomal cholesterol transport by inhibition of low-density lipoprotein-induced esterification of cholesterol and cause unesterified cholesterol to accumulate in perinuclear vesicles. It has been suggested the possibility that endogenous sphinganine may inhibit cholesterol transport in Niemann-Pick Type C (NPC) disease. (PMID 1817037)

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines


Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines